ZS PHARMA INC's ticker is ZSPH and the CUSIP is 98979G105. A total of 122 filers reported holding ZS PHARMA INC in Q2 2015. The put-call ratio across all filers is 0.13 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $1,048,000 | – | 20,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 564,483 | $22,145,000 | 2.62% |
| Redmile Group, LLC | 474,132 | $18,600,000 | 2.15% |
| Novo Holdings A/S | 506,730 | $19,879,000 | 1.94% |
| Ghost Tree Capital, LLC | 85,000 | $3,335,000 | 1.81% |
| VHCP Management, LLC | 100,000 | $3,923,000 | 1.76% |
| Atika Capital Management LLC | 31,000 | $1,216,000 | 0.94% |
| PFM Health Sciences, LP | 729,044 | $28,600,000 | 0.66% |
| WALL STREET ASSOCIATES | 143,400 | $5,626,000 | 0.58% |
| Rock Springs Capital Management LP | 92,000 | $3,609,000 | 0.56% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 136,204 | $5,343,000 | 0.51% |